intranasal
Union Health Minister launches first made-in-India intranasal Covid vaccine –
By PTI NEW DELHI: Union Health Minister Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched Bharat Biotech’s nasal Covid ...
India’s first intranasal Covid vaccine to be launched on Jan 26-
By PTI BHOPAL: Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind ...
Bharat Biotech’s intranasal COVID-19 vaccine to cost Rs 800 for private markets-
By PTI HYDERABAD: Bharat Biotech International Limited on Tuesday said its covid-19 intranasal vaccine iNCOVACC, which is now available on ...
Bharat Biotech’s intranasal Covid vaccine approved by govt, to be available on CO-WIN
NEW DELHI: Bharat Biotech’s intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose for ...
Bharat Biotech’s intranasal Covid vaccine gets government approval, to be available on CO-WIN –
By Express News Service NEW DELHI: India’s first intranasal Covid vaccine was approved by the Union Health Ministry and will ...
Bharat Biotech’s intranasal Covid vaccine approved by govt, to be available on CO-WIN-
By PTI NEW DELHI: Bharat Biotech’s intranasal Covid vaccine has been approved by the Union Health Ministry for inclusion in ...
Bharat Biotech urges Centre to include its intranasal COVID vaccine in CoWIN portal
Hyderabad: Bharat Biotech has requested the central government to include its intranasal COVID-19 vaccine iNCOVACC, in CoWIN portal to enable ...
Bharat Biotech urges Centre to include its intranasal covid vaccine in CoWIN portal-
By PTI HYDERABAD: Bharat Biotech has requested the central government to include its intranasal covid-19 vaccine iNCOVACC, in CoWIN portal ...
Intranasal vaccine iNCOVACC gets restricted use nod-
Express News Service NEW DELHI: India’s first nasal Covid vaccine iNCOVACC has received approval from the Central Drugs Standard Control Organisation ...
Drug regulator’s nod sought for third phase study of intranasal Covid vaccine in 5-18 age group-
By PTI NEW DELHI: Hyderabad-based firm Bharat Biotech has sought permission from the drug regulator to conduct phase-3 study of ...
